在小鼠肝脏中,CRY1/2通过抑制E4BP4调节节律性CYP2A5
Luomin Lin1, Yuwei Huang2, Jinyi Wang3
1College of Pharmacy, Jinan University, Guangzhou, China.
Biochemical pharmacology
|October 5, 2023
概括
循环时钟蛋白CRY1和CRY2通过抑制E4BP4.4来调节肝酶CYP2A5的表达和活性. 这一发现澄清了药物代谢节律的机制.
科学领域:
- 时间生物学 时间生物学
- 分子药理学分子药理学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 细胞染色体P450 2A5 (CYP2A5) 在表达和活性方面表现出昼夜节律,这对药物代谢至关重要.
- 控制CYP2A5的昼夜调节的精确分子机制仍然不完全理解.
研究的目的:
- 研究日间钟蛋白CRY1和CRY2在肝脏CYP2A5.5日间调节中的作用.
- 阐明CRY1/2影响CYP2A5表达和活性的分子机制.
主要方法:
- 使用Cry1-null和Cry2-null小鼠模型进行体内研究.
- 使用AML-12,Hepa1-6和HepG2细胞系进行体外验证.
- 通过库马林7-氧化来评估CYP2A5活性,并使用qPCR和西式涂抹来量化mRNA/蛋白质水平.
- 使用 luciferase 记者测定,ChIP 和 Co-IP 的调控机制进行了研究.
主要成果:
- 在小鼠中切除Cry1或Cry2导致肝脏CYP2A5mRNA和蛋白质水平降低,并取消了白天节律.
- 在淘汰赛小鼠中,CYP2A5活性下降并失去其时间依赖性,与肝毒性增加相关.
- 基于细胞的测定证实CRY1/2积极调节CYP2A5表达及其昼夜节律.
- 发现CRY1/2与E4BP4相互作用,从而抑制E4BP4对Cyp2a5转录的抑制作用.
结论:
- CRY1和CRY2是小鼠肝脏中节律性CYP2A5表达和活性的关键调节者.
- 该机制涉及CRY1/2抑制E4BP4在Cyp2a5转录上的抑制作用.
- 这些发现提高了对药物代谢和药理动力学的昼夜控制的理解.
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Eukaryotic Transcription Inhibitors
9.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.9K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K


